Document:

Sales Agent Agreement dated February 14, 2003

 Exhibit 10.7 
  
 SALES AGENT AGREEMENT 
  
 THIS SALES AGENT AGREEMENT (“Agreement”), is made by and between, ALTUS MEDICAL, INC., a Delaware corporation with offices located at 821 Cowan
Road, Burlingame, CA, 94010 (“Altus”), and PSS World Medical, Inc., a Florida corporation, with offices located at 4345 Southpoint Boulevard, Jacksonville, Florida 32216 (hereinafter “PSS”) effective this 14th day of February, 2003 (the “Effective Date”). 
  
 Recitals 
  
 A. Altus is engaged in the development, manufacturing and marketing of aesthetic laser systems and related services. 
  
 B. PSS is experienced with the promotion, distribution and sale of medical
equipment and related supplies and services. 
  
 C. The parties
desire that PSS act as a sales agent for products manufactured by Altus pursuant to the terms and conditions of this agreement (the “Agreement”). 
  
 Agreement  
  
 In consideration of the matters stated in the Recitals hereto and the mutual covenants contained in this Agreement the parties agree as follows:

  
 1.0 DEFINITIONS. When used in this Agreement, each of the following
terms shall have the definition set out below: 
  
 1.1 Agreement means this Agreement, together with all Exhibits which are attached hereto or incorporated by reference herein, and which are an integral part hereof. 
  
 1.2 Commission Schedule means the commission schedule attached hereto as Exhibit A. 
  
 1.3 PSS Territory means only the United States.

  
 1.4 Products means Altus’
CoolGlide CV-, CoolGlide Excel-, and CoolGlide Vantage laser systems. In the event Altus manufacturers, markets or sells new or different products other than the foregoing Products, the parties agree that they will first discuss the possibility of
PSS becoming a sales agent for such products prior to Altus approaching, soliciting or discussing with any other third party a possible sales agency relationship for the sale of such products to Physicians in the PSS Territory. Notwithstanding any
other term in this Agreement, Altus may from time to time discontinue the manufacture and/or sale of any or all Products, and/or change its pricing, service policies, warranties, credit requirements, product designs, and terms of sale without any
obligation or liability to PSS; provided, that Altus will not, without PSS’ consent, sell a Product outside the range as provided in Altus’ then-current pricing matrix. 
  

 2.0 APPOINTMENT. 
  
 2.1 Sales Agent. Subject to the terms and conditions of this Agreement, Altus hereby appoints PSS as its authorized U.S. sales
agent with exclusive rights solely to promote and solicit orders for sales of the Products to licensed physicians (“Physicians”) for delivery and use within the PSS Territory. Notwithstanding the foregoing (but subject to Altus’
obligations to pay PSS for commissions earned hereunder), Altus shall have the right, without any compensation owing to PSS, to market and sell Products in the PSS Territory through its employees and third-party leasing companies, however, Altus
will not, during this Agreement, authorize any third-party sales agent to market or sell the Product(s) to Physicians in the PSS Territory. 
  
 2.2 Competitive Products. During the Term of this Agreement, PSS shall not engage, either directly or indirectly, in the
manufacture, marketing, promotion or sale of products that are similar to or competitive with the Products covered by this Agreement, unless Altus and PSS agree in advance in writing. Notwithstanding the foregoing, PSS shall have the right to sell
its remaining inventory of the Candela V Beam lasers. 
  
 2.3 Nature of Relationship. In entering into this Agreement. PSS does so as an independent contractor and not as a franchisee, partner or joint venturer. PSS does not have any right or authority, nor shall PSS hold itself out as
having any right or authority, to assume, create or enter into any contract or obligation, either express or implied, on behalf of, in the name of, or binding upon, Altus. PSS will make no representations or warranties, or incur any liabilities, for
which Altus may be obligated, without first having obtained Altus’ written consent. 
  
 2.4 Orders. PSS will not accept orders in Altus’ name, or make quotations of price or other terms, without Altus’ prior
written approval. Altus will have the sole right, without any liability or obligation to PSS, to: provide sales quotes; establish and modify pricing and all other terms and conditions of sales; reject any orders and/or offers; disapprove the credit
of any customers; accept or reject the return of its Products from any customers; and, make allowances and/or give any credits, discounts or adjustments it deems appropriate to any customers. PSS will forward promptly to Altus all monies or
remittances in any form which PSS may receive by customers. Invoices will be sent by Altus directly to the customer. 
  
 3.0 SALES PROCEDURE 
  
 3.1 The parties agree to meet, discuss and cooperate in good faith in order to agree on and implement mutually beneficial policies and
procedures with respect to the marketing, solicitation and sales of the Products, including without limitation those relating to the identification of leads and prospective customers (“Prospects”), marketing and solicitation activities,
and closing of sales to Prospects. In this regard, the Market Manager for PSS (“Market Manager”) and the Vice President of Sales for Altus shall take the lead in such discussions toward reaching mutual agreement on such details.

  
 3.2 Subject to the specific polices and
procedures that are hereafter agreed upon by the parties in writing, the Market Manager shall submit the Prospect information to Altus via email. Altus will then determine whether the Prospect is currently being actively pursued by Altus (an
“Altus Prospect”). For purposes of this Agreement, a Prospect will be considered an “Altus 
  

 2 

 Prospect” if, for example, Altus has engaged in bilateral discussions with the Prospect (as opposed to, for example,
an unanswered solicitation from Altus). Altus shall provide to PSS on a regular basis a current, accurate and complete list of all Altus Prospects. 
  
 3.3 In the event the Prospect is not an Altus Prospect, an Altus Sales Representative (as defined below) shall promptly follow up with the
Prospect. Altus shall use commercially reasonable efforts to consummate a sale with the Prospect within one hundred and twenty (120) days after the Prospect information is first submitted by PSS to Altus. 
  
 3.4 In the event a sale is consummated within one hundred
and twenty (120) days after the Prospect information is first submitted by PSS to Altus, PSS shall be entitled to a commission on such sale pursuant to the Commission Schedule attached as Exhibit A. Commissions, which will be the sole compensation
for PSS’ performance under this Agreement, shall be based on the net selling price of the Product(s), less amounts for discounts; returns; allowances and credits issued by Altus or taken by customers; purchase, sales, or other similar taxes;
freight and insurance; and duties (“Net Selling Price”). Overpayments in commissions may be deducted from commissions subsequently earned. Additionally, in the event a customer, who has purchased a Product for which PSS earned a commission
hereunder, purchases an upgrade from Altus of that Product under circumstances which, if that upgrade were a Product, then PSS would have earned a commission hereunder, then PSS shall earn a commission on the sale of that Product upgrade in the
amounts as set forth on Exhibit A. 
  
 4.0 PSS OBLIGATIONS 
  
 4.1 PSS shall use commercially reasonable efforts to
promote, market and solicit orders for the Products, and to represent the interests of Altus at all times, to Physicians in the PSS Territory. PSS will also assist in collections of customer payments by performing such reasonable tasks as reminding
delinquent customers that they are late in payments. 
  
 4.2 PSS shall, at its expense, maintain a properly trained sales force of adequate size to represent and promote the sale of the Products to Physicians throughout the PSS Territory. All of PSS’s sales staff shall be employees of PSS.
PSS recognizes and agrees that Altus will be working cooperatively with PSS’s sales persons, including efforts to qualify leads and conduct demonstrations. 
  
 4.3 PSS shall, for at least three years from their respective dates of creation, maintain accurate books and
records of marketing and sales activities relating to Products, Prospects, Altus Prospects and PSS’ obligations under this Agreement as may be reasonably necessary to document compliance with the terms of this Agreement. Upon the reasonable
request of Altus no more than once in any 12-month period, PSS shall permit Altus to inspect and audit such books and records in order to confirm PSS’ compliance with the terms of this Agreement. 
  
 5.0 ALTUS OBLIGATIONS. 
  
 5.1 Altus shall, at its expense, contribute the personnel resources of its U.S. sales force (“Altus
Sales Representatives”) to help support PSS in its efforts under this Agreement. 
  

 3 

 These persons shall be properly trained, knowledgeable, experienced and qualified with respect to all Products, and shall
be geographically located strategically throughout the United States. 
  
 5.2 Altus shall provide demonstrations of the Product to Prospects as needed, and will provide all installation work for Products. PSS will not provide any product demonstrations and will not perform any product
installation services. Altus agrees to provide sales and promotional support and after-sale service support to all Prospects and customers referred by PSS to Altus with the same diligence, quality and timeliness as Altus provides to Altus Prospects
and direct customers. 
  
 5.3 Altus will provide,
at its expense, sales literature, marketing material, and appropriate competitive information (“Marketing Materials”), in such quantities as may hereafter be agreed in writing by the parties, for use by PSS in connection with its
marketing, promotion and sales efforts hereunder. Altus shall immediately provide notice to PSS of any inaccuracies, mistakes or incorrect statements in any Marketing Materials, and shall promptly provide to PSS any revised, updated or new Marketing
Materials in such quantities as may hereafter be agreed in writing by the parties. All Marketing Materials are, and shall remain, Altus’ property, and will be returned promptly by PSS upon Altus’ request or upon the termination of this
Agreement, whichever is first to occur. 
  
 5.4
Altus will provide with respect to all new Products sold its then-current product warranty. 
  
 5.5 Altus shall include PSS as an additional insured on Altus’ product liability and commercial general liability insurance policies.
A certificate of insurance for two million dollars ($2,000,000) evidencing PSS as such additional insured is available upon request. 
  
 5.6 Altus shall provide initial training to PSS sales representatives and leaders. Such training shall include lecture and hands on
demonstrations on the use and application of all Products. Each party shall be responsible for its own costs and expenses, including employee and travel expenses, in connection with such training. 
  
 5.7 Altus shall, for at least three years from their
respective dates of creation, maintain accurate books and records of marketing and sales activities relating to Products, Prospects, Altus Prospects and Altus’ obligations under this Agreement as may be reasonably necessary to document
compliance with the terms of this Agreement. Upon the reasonable request of PSS no more than once in any 12-month period, Altus shall permit PSS to inspect and audit such books and records in order to confirm Altus’ compliance with the terms of
this Agreement. 
  
 6.0 REGULATORY COMPLIANCE AND APPROVAL. 
  
 6.1 Altus shall be responsible to ensure that the design and
production of the Products conform to the laws and regulations administered by the U.S. Food and Drug Administration (FDA) and to the state and federal laws and regulations of any applicable governmental authority or jurisdiction within the PSS
Territory. 
  

 4 

 6.2 PSS shall be responsible for complying with all laws, regulations and rules which may
be applicable to the marketing or selling of the Product in the PSS Territory. Specifically, but without limitation, PSS shall be responsible for any applications, licenses, or other submittals or approvals required by regulations or rules related
to the marketing or selling of the Products in the PSS Territory and PSS shall comply with such laws, regulations or rules at its own expense. 
  
 7.0 PRODUCT WARRANTY AND LIMITATIONS. 
  
 7.1 Product Warranty. Products sold pursuant to this Agreement will come with Altus’ then-current product warranty, which will
be for the customer’s benefit. 
  
 7.2
Disclaimer of Warranties. EXCEPT AS SET FORTH IN SECTION 7.1, ALTUS MAKES NO OTHER WARRANTIES, WHETHER EXPRESS OR IMPLIED, AND ALTUS EXCLUDES AND DISCLAIMS ALL OTHER WARRANTIES INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. NEITHER PARTY SHALL HAVE LIABILITY FOR INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES RELATING TO THIS AGREEMENT AND/OR THE SALE OR USE OF THE PRODUCTS. 
  
 7.3 Survival. The terms and conditions of this
Section 7 shall survive the termination or expiration of this Agreement. 
  
 8.0
PRICE AND PAYMENT TERMS. 
  
 8.1 Price
Schedule. The prices to be quoted by PSS for Products shall be provided in writing by Altus to PSS. Altus shall promptly notify PSS in writing of any price changes. PSS will not quote any prices outside the range of Altus’ pricing matrix
without Altus’ prior written consent, which must be given in each instance. 
  
 8.2 All commissions earned by PSS hereunder shall be paid to PSS no later than the 30th day of the month following the month in which the commission was earned. The commission shall be earned, during this Agreement or within 120 days thereafter,
at the time Altus submits an invoice to the customer for the underlying Product(s) or Product upgrade(s). Notwithstanding the foregoing, if a customer has not made full payment to Altus within 90 days from an invoice’s date, then Altus will
have the right to offset the corresponding portion of the commission that had been paid to PSS. If that customer ultimately brings its balance current, Altus will then re-issue the commission that it had earlier offset. Altus shall pay interest to
PSS at the lower of (a) eighteen percent (18%) per annum or (b) the highest amount permitted by law on all amounts not paid to PSS within thirty (30) days of their due date. With each payment to PSS, and no less than monthly, Altus shall submit a
detailed report identifying all sales of Products during the prior period for which payment of commission is being made. 
  

 5 

 9.0 CONFIDENTIALITY. 
  
 9.1 Return of Confidential Information. Each party shall return to the other all Confidential Information (as defined below)
received from that other party, along with all copies, immediately upon the termination of this Agreement. 
  
 9.2 Remedies. Each party shall be liable to the other for damages caused by any breach of this Section 9 or by any unauthorized
disclosure or use of the other’s Confidential Information by such party or third parties to whom unauthorized disclosure was made. In addition to any other rights or remedies which may be available to it, each party shall be entitled to seek
appropriate injunctive relief or specific performance to prevent unauthorized use or disclosure of Confidential Information. Each party acknowledges and agrees that the unauthorized use or disclosure of the other party’s Confidential
Information will cause irreparable injury to the other party and that money damages will not provide adequate remedy to the other party. 
  
 9.3 Confidential Information. The business and technical information developed or acquired by, or entrusted by a third party to,
each party (“Confidential Information”) are the exclusive property of such party, are among such party’s most valuable assets, and their value to that party may be lost by their unauthorized use or disclosure to persons or entities
not related to such party. Confidential Information includes, among other things, all lists of customers, all Product designs and manufacturing processes, Product pricing and pricing strategies, business plans, and all related trade secrets. Neither
party shall, directly or indirectly, use the other party’s Confidential Information received hereunder (other than directly in connection with its obligations hereunder) or disclose or disseminate it to any party or entity during the Term of
this Agreement or at any time during the three (3) year period after the expiration of this Agreement, regardless of the reason for such expiration, without the express written consent of the other party. This obligation of confidentiality shall not
apply to any Confidential Information which (i) was known to the receiving party at the time of receipt without any misconduct on the receiving party’s part; (ii) was in the public domain at the time of receipt; (iii) becomes public through no
wrongful act of the party obligated to keep it confidential; (iv) is received by the receiving party from a third party who did not thereby violate any confidentiality obligations to the disclosing party; or (v) is required by applicable law to be
divulged 
  
 9.4 Sections 9.1, 9.2 and 9.3 of
this Section shall survive the termination or expiration of this Agreement. 
  
 9.5 The parties agree that their September 19, 2002 Confidentiality Agreement is hereby terminated by mutual consent. 
  
 10.0 REPRESENTATIONS AND WARRANTIES. 
  
 10.1 PSS, represents, warrants and/or covenants to Altus that: 
  
 (a) PSS is and will continue to be a duly formed and validly existing entity in good standing under the laws
of the state of its organization 
  

 6 

 (b) PSS has full right, power and authority, corporate and/or otherwise, to execute and
deliver this Agreement and to otherwise consummate the transactions contemplated by this Agreement. 
  
 (c) The execution, delivery and performance by PSS under this Agreement, and the transactions and actions contemplated hereunder, have
been duly authorized by all necessary action by PSS. This Agreement, when duly executed and delivered, constitutes a valid, legal and binding obligation of PSS enforceable in accordance with its terms. 
  
 (d) The execution, consummation of the transactions
contemplated by, and/or compliance with the terms and provisions of this Agreement, will not conflict with, result in a breach of, or constitute a default under any of the terms, conditions or provisions of PSS’s constituent documents or any
agreement, lease, indenture, mortgage, deed of trust, land contract, license or other instrument to which PSS is a party or by which PSS may be bound or affected or to which PSS is subject, or any law, regulation, order, writ, injunction or decree
of any court or agency or regulatory body. 
  
 10.2 Altus, represents, warrants and/or covenants to PSS that: 
  
 (a) Altus is and will continue to be a duly formed and validly existing entity in good standing under the laws of the state of its organization 
  
 (b) Altus has full right, power and authority, corporate and/or otherwise, to execute and deliver this
Agreement and to otherwise consummate the transactions contemplated by this Agreement. 
  
 (c) The execution, delivery and performance by Altus under this Agreement, and the transactions and actions contemplated hereunder, have
been duly authorized by all necessary action by Altus. This Agreement, when duly executed and delivered, constitutes a valid, legal and binding obligation of Altus enforceable in accordance with its terms. 
  
 (d) The execution, consummation of the transactions
contemplated by, and/or compliance with the terms and provisions of this Agreement, will not conflict with, result in a breach of, or constitute a default under any of the terms, conditions or provisions of Altus’ constituent documents or any
agreement, lease, indenture, mortgage, deed of trust, land contract, license or other instrument to which Altus is a party or by which Altus may be bound or affected or to which Altus is subject, or any law, regulation, order, writ, injunction or
decree of any court or agency or regulatory body. 
  
 11.0 INDEMNIFICATION.

  
 11.1 PSS shall and does hereby agree to
indemnify and hold harmless Altus and its affiliates from and against any and all liability, loss, cost, claim, injury, damage, demand or expense (including, without limitation, reasonable attorneys’ fees) of any kind whatsoever arising out of,
on account of, or in connection with (a) any instruction, specification or labeling supplied by PSS regarding the Product, unless Altus has concurred in writing with such instruction, specification or labeling; (b) any use of the Product in a manner
described by PSS, unless Altus 
  

 7 

 has prescribed such use in written materials; (c) any marketing, sale, installation, servicing or repair of the Product
by PSS not in accordance with Altus’ written consent and procedures; (d) any breach by PSS of this Agreement; or (e) PSS’ negligence or willful misconduct. This Indemnity shall survive the termination or expiration of this Agreement.

  
 11.2 Altus Indemnification. 
  
 (a) Altus agrees to indemnify and hold harmless PSS and its
affiliates from and against any loss, liability, claim, or damage (including reasonable attorneys fees) sustained by it or them as a result of any (i) breach by Altus of this Agreement or (ii) claim that the Product(s) infringe any patent,
copyright, trade secret, or other intellectual property right of any third party; provided, that PSS notifies Altus immediately of any such claim, cooperates with Altus in the defense thereof, and allows Altus, at Altus’ option, to fully
control the defense thereof with Altus’ own counsel. If such a claim arises, or in Altus’ judgment is likely to arise, PSS agrees to allow Altus, at Altus’ option and expense, to procure the right for PSS and all customers to continue
to exercise their rights in the Product(s) or to replace or modify them in an equivalent manner (i.e., without adversely affecting the functionality or compatibility of the Products) so they become non-infringing, and any such actions will not be
deemed to be a breach of this Agreement. If neither of the foregoing alternatives is available on terms that are commercially reasonable in Altus’ reasonable judgment, PSS, upon written request by Altus or the customers, shall cease all
infringing activity relating to the Products, and neither party will be deemed to be in breach of this Agreement. The foregoing remedial actions, however, shall not relieve Altus of its indemnity obligations with respect to any loss, liability, or
damage that has or may be incurred with respect to existing Product(s) prior to the cessation of the infringement. Altus shall have no obligation under this Section 11.2 with respect to any claim of infringement based upon PSS’s or any
customer’s modification of the Product(s) or their combination, operation, or use with programs or equipment, but only insofar as such infringement would otherwise have been avoided bur for such modification, combination, operation or use. THE
FOREGOING IS ALTUS’ SOLE LIABILITY RELATING TO ANY CLAIMS OF INFRINGEMENT OF ANY THIRD PARTY INTELLECTUAL PROPERTY RIGHTS. ALTUS EXPRESSLY DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS OR IMPLIED, RELATING TO CLAIMS THAT ITS PRODUCTS INFRINGE
ANY INTELLECTUAL PROPERTY RIGHTS. 
  
 (b)
Property Damage and Personal Injury. Altus agrees to indemnify and hold harmless PSS and its affiliates from and against any loss, liability, claim, injury or damage (including reasonable attorneys fees) sustained by it as a result of any
claim by any third party for property damage, or personal injury or death suffered by a third party to the extent such damage or injury is caused by Altus’ negligence, willful misconduct or breach of this Agreement, or any defect in the design
or manufacture of the Product(s). 
  
 (c) This
indemnity shall survive the termination or expiration of this Agreement. 
  
 11.3 Procedure. With respect to any claim for which indemnification is available hereunder, the indemnified party shall (a) provide prompt notice of such claim to the indemnifying party, (b) reasonably
cooperate with the indemnifying party with respect to the investigation and defense of the claim and (c) permit the indemnifying party to control the defense and settlement of the claim. 
  

 8 

 12.0 LIMITATION OF LIABILITY. 
  
 NOTWITHSTANDING ANY OTHER TERM IN THIS AGREEMENT, NEITHER PARTY SHALL BE LIABLE FOR ANY LOSS OF USE, REVENUE OR ANTICIPATED
PROFITS, OR FOR ANY SPECIAL, INDIRECT, INCIDENTAL, EXEMPLARY OR CONSEQUENTIAL DAMAGES RELATING TO OR IN CONNECTION WITH THIS AGREEMENT OR THE SALE OR USE OF THE PRODUCTS. 
  
 13.0 FORCE MAJEURE. 
  
 If either party’s performance of any of its obligations is prevented, restricted, or interfered with by reason of fire, or other
casualty or accident, strikes or labor disputes, inability to procure raw materials, delays in transportation, power or supplies, war or other violence, including acts of terrorism, any law, order, proclamation, regulation, ordinance, demand or
requirement of any government agency, or any other act or condition whatsoever beyond the reasonable control of the parties hereto, the party, upon giving reasonable notice to the other party, shall be excused from such performance to the extent of
such prevention, restriction or interference, provided that such party shall use commercially reasonable efforts to avoid or remove such causes of non-performance and shall continue performance hereunder with reasonable dispatch whenever such causes
are removed. Notwithstanding the foregoing, if a party’s performance is prevented, restricted or interfered with for more than ninety days due to a force majeure event, then the other party may terminate this Agreement by written notice without
any liability. 
  
 14.0 TERM AND TERMINATION. 
  
 14.1 Term. The initial term of this Agreement shall
commence on the Effective Date and continue until December 31, 2005. Following the initial term, this Agreement will be automatically renewed and extended for additional successive one (1) year terms, unless either party gives written notice to the
other party of the party’s intention and desire to terminate this Agreement no later than ninety (90) days prior to expiration of the then current term. The initial term together with any renewal terms shall be referred to herein as the
“Term”. 
  
 14.2 Automatic
Termination and Termination Without Cause. 
  
 (a) Unless Altus notifies PSS to the contrary in writing, this Agreement will terminate immediately and without notice upon the institution of insolvency, bankruptcy or similar proceedings by or against PSS, any assignment or attempted
assignment by PSS for the benefit of its creditors, or any appointment or application for appointment, of a receiver for PSS. 
  
 (b) Unless PSS notifies Altus to the contrary in writing, this Agreement will terminate immediately and without notice upon the
institution of insolvency, bankruptcy or similar proceedings by or against Altus, any assignment or attempted assignment by Altus for the benefit of its creditors, or any appointment or application for appointment, of a receiver for Altus.

  

 9 

 (c) Notwithstanding Section 14.1, either party may terminate this Agreement, without
cause, by delivering a written notice to the other party anytime after September 30, 2003, which termination will take effect 90 days following delivery of such written notice. If PSS serves notice of termination, then Altus may appoint other
persons to solicit orders for sales of Products to Physicians within the PSS Territory after thirty (30) days following such notice. If Altus serves notice of termination, then Altus may appoint other persons to solicit orders for sales of Products
to Physicians within the PSS Territory after ninety (90) days following such notice. In either event, PSS and Altus agree to work cooperatively in this transition period. 
  
 14.3 Termination for Cause. 
  
 (a) Either party may terminate this Agreement upon written notice to the other party if such other party
breaches a material term, condition or representation hereof and fails to cure the same within thirty (30) days after receipt of written notice of such breach. 
  

14.4 Remedies for Breach. 
  
 (a) PSS agrees that money damages would not be a sufficient remedy for any breach of Section 9 of this Agreement and that Altus shall be
entitled to seek injunctive or other equitable relief as a remedy for any such breach, in addition to any other remedies it may have at law or otherwise. 
  
 (b) Altus agrees that money damages would not be a sufficient remedy for any breach of Section 9 of this Agreement and that PSS shall be
entitled to seek injunctive or other equitable relief as a remedy for any such breach, in addition to any other remedies it may have at law or otherwise. 
  
 14.5 Immediately upon the termination of this Agreement for any reason, PSS will cease soliciting orders for the Products, will stop
representing Altus in any manner, and will return to Altus at PSS’ expense all price lists, catalogs, materials, equipment, instruments, products, demo units, samples and all other items that were furnished by or through Altus to PSS hereunder.

  
 15.0 INTELLECTUAL PROPERTY RIGHTS. 
  
 15.1 All intellectual property rights relating to Altus, the
Products and this Agreement, including all names, trademarks, copyrights, patents, mask works, trade secrets, know-how, technology, computer software and related documentation and source code and other intellectual property rights, are and shall
remain the property of Altus and nothing in this Agreement shall be deemed to grant to PSS a license or other right to use Altus’ intellectual property except as expressly set forth herein. Altus hereby grants PSS the right to use its names and
trademarks to perform its duties pursuant to the terms of this Agreement and solely in compliance with such rules as Altus may establish from time to time. PSS will not create or distribute any marketing or promotional material relating to Altus or
the Products without Altus’ prior written consent. 
  

 10 

 16.0 GENERAL. 
  
 16.1 Entire Agreement. This Agreement constitutes the entire Agreement between the parties concerning the subject matter hereof and
supersedes any prior written or verbal agreements or understandings in connection herewith. No amendment, waiver or modification hereto or hereunder shall be valid unless specifically made in writing and signed by an authorized signatory of each of
the parties hereto. 
  
 16.2 Notices. All
notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail or delivered either by hand or by messenger, or sent via fax, addressed to the address set forth at the foot of
this Agreement. Any notice or other communication so addressed and mailed by registered or certified mail (in each case, with return receipt requested) shall be deemed to be delivered and given when so mailed. Any notice or other communication so
addressed and delivered by hand, by messenger or by fax shall be deemed to be given when actually received by the addressee. 
  
 16.3 Choice of Law and Forum  
  
 (a) This Agreement shall be governed by and construed in accordance with the substantive laws of the State of New York without regard to
its conflicts of laws rules or principles. 
  
 (b) Neither party shall commence any litigation against the other arising out of this Agreement or its termination except in a court located where the defendant party’s headquarters are located. Each party consents to jurisdiction over
it by and exclusive venue in those courts. Altus and PSS may, however, seek injunctive relief as contemplated by the terms of this Agreement or applicable law in any court of competent jurisdiction. 
  
 (c) In any action relating to this Agreement, the prevailing
party shall be entitled to recover reasonable attorneys’ fees and other costs incurred therein, in addition to any other appropriate relief. 
  
 16.4 Severability. If for any reason any provision of this Agreement shall be deemed by a court of competent jurisdiction to be
legally invalid or unenforceable, the validity of the remainder of the Agreement shall not be affected and the offending provision shall be deemed modified to the minimum extent necessary to make it consistent with applicable law, and, in its
modified form, the provision shall then be enforceable and enforced. 
  
 16.5 Survival. The parties agree that Sections 4.3, 5.5, 5.7, 7, 9-13, 15 and 16 shall survive termination or expiration of this Agreement, together with any other provisions that the parties would reasonably
contemplate as remaining in effect after termination or expiration of this Agreement. 
  
 16.6 Captions. The section headings and captions of this Agreement are for convenience and reference only and in no way define,
limit or describe the scope or intent of this Agreement nor substantively affect it in any way. 
  

 11 

	

 16.7 Binding Effect; Assignment. This Agreement shall be binding on
and shall inure to the benefit of the parties and their respective representatives, successors and permitted assigns; provided, however, that neither party shall have the right to transfer or assign any rights or obligations under this Agreement
(other than transfers or assignments by operation of law) without first obtaining the other party’s written consent. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement to be executed by their duly authorized representatives on the date first
above written. 
  

									
	 Altus Medical, Inc.,
 a Delaware
corporation
	 	 	 	 PSS WORLD MEDICAL,INC.,
 a Florida corporation

					
	By:	 	/s/     Ron Santilli        	 	 	 	By:	 	/s/    John Sasen         
	 	 	
	 	 	 	 	 	

	Printed:	 	Ron Santilli	 	 	 	 	 	 John Sasen
 Chief Marketing
Officer

	 	 	
	 	 	 	 	 	 
					
	Its:	 	 VP and CFO
	 	 	 	 	 	 (“PSS”)

	 	 	
	 	 	 	 	 	 
	 	 	 (“Altus”)
	 	 	 	 	 	 

  

			
	Address for Notices:	 	Address for Notices:
	 Altus Medial, Inc.
 821 Cowan Road
 Burlingame, CA 94010
 Attn: President
 Telephone: (650) 552-9700
 Telecopier: (650) 552-9787
	 	 John Sasen
 Chief
Marketing Officer
 PSS World Medical, Inc.
 4345 Southpoint Blvd.
 Jacksonville, Florida 32216
 Telephone: (904) 332-3345
 Telecopier:
(904) 332-3205

		
	With a copy to:	 	With a copy to:
		
	 Altus Medial, Inc.
 821 Cowan Road
 Burlingame, CA 94010
 Attn: General Counsel
 Telephone: (650) 552-9700
 Telecopier: (309) 218-0641
	 	 Charles E. Commander III, Esq.
 Foley & Lardner
 200 Laura Street
 Jacksonville, Florida 32202
 Telephone: (904) 359-2000
 Telecopier: (904) 359-8700

  
  

 12 

 EXHIBIT A 
  

Commission Schedule 
  
 Subject to the terms of this Agreement, the following commission schedule will apply to all sales of Products PSS solicits from Physicians in the PSS Territory
(“Sales”) and that are shipped between the Effective Date and December 31, 2003, inclusive (“First Year”). The commission schedule for any subsequent period will be negotiated by the parties in good faith at least two months
before the start of such subsequent period. 
  
 - CoolGlide CV: PSS’s
commission rate is [****] of the Net Selling Price 
  
 - Excel: 
  

			
	 For that portion of total units sold in the First Year that are
between:

	 	 PSS’ commission rate will be the following percentage of the
corresponding Net Selling Price:

	    0 – 25
	 	[****]
	  26 – 50
	 	[****]
	 51 – ¥
	 	[****]

  
 - Vantage: 
  

			
	 For that portion of total units sold in the First Year that are
between:

	 	 PSS’ commission rate will be the following percentage of the
corresponding Net Selling Price:

	    0 – 25
	 	[****]
	  26 – 50
	 	[****]
	 51 – ¥
	 	[****]

  
 Also, if a customer, who has
purchased a Product for which PSS earned a commission hereunder, purchases an upgrade from Altus of that Product under circumstances which, if that upgrade were a Product, then PSS would have earned a commission hereunder, then PSS will earn a
commission on the sale of that Product upgrade in the amounts of [****] of that Product upgrade’s Net Selling Price. 
  
 **** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 
  

 13 

 AMENDMENT NO. 1 TO SALES AGENT AGREEMENT 
  
 This Amendment No. 1 To Sales Agent Agreement (“Amendment No. 1”) is made this
17th day of March, 2003, between Altus Medical, Inc. (“Altus”) and PSS World Medical, Inc.
(“PSS”). 
  
 WHEREAS, Altus and PSS entered into that February 14, 2003
Sales Agent Agreement (“Agreement”), and are hereby amending the Agreement as follows: 
  

	1.	The first sentence of Section 1.4 is amended and replaced with the following: 

  

“Products means Altus’ CoolGlide CV-, CoolGlide Excel-, CoolGlide Vantage-, CoolGlide Genesis-, CoolGlide Xeo- and CoolGlide Genesis Plus laser
systems; provided, that neither Altus’ CoolGlide Xeo-, nor its CoolGlide Genesis Plus laser system, will be deemed a “Product” until after Altus has received all necessary government approval to sell such laser system in the
Territory.” 
  

	2.	Exhibit A is amended and replaced with the following: 

  
 “Commission Schedule 
  
 Subject to the terms of this Agreement, the following commission schedule will apply to all sales of Products PSS solicits from Physicians in the PSS
Territory (“Sales”) and that are shipped between the Effective Date and December 31, 2003, inclusive. The commission schedule for any subsequent period will be negotiated by the parties in good faith at least two months before the start of
such subsequent period. 
  

	 	-	CoolGlide CV: PSS’s commission rate is [****] of the Net Selling Price 

  

	 	-	CoolGlide Excel, CoolGlide Vantage, CoolGlide Genesis, CoolGlide Xeo and CoolGlide Genesis Plus: PSS’s commission rate is [****] per unit Sale. 

  
 Also, if a customer, who has purchased a Product for which PSS earned a
commission hereunder, purchases an upgrade from Altus of that Product under circumstances which, if that upgrade were a Product, then PSS would have earned a commission hereunder, then PSS will earn a commission on the sale of that Product upgrade
in the amounts of [****] of that Product upgrade’s Net Selling Price.” 
  
 The capitalized terms that are used, but not defined, in this Amendment shall have the same definitions provided in the Agreement. Except as expressly stated in this Amendment, the Agreement shall remain unmodified and in full force and
effect. 
  

									
	 Altus Medical, Inc.
	 	 	 	 PSS WORLD MEDICAL, INC.

					
	 By:
	 	 /s/    Kevin Connors

	 	 	 	 By:
	 	 /s/    John F. Sasen, Sr.

					
	 Printed:
	 	 Kevin Connors

	 	 	 	 Printed:
	 	 John F. Sasen, Sr.

					
	 Its:
	 	 CEO

	 	 	 	 Its:
	 	 Executive Vice President

  
 ****    Certain
information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 AMENDMENT NO. 2 TO SALES AGENT AGREEMENT 
  
 This Amendment No. 2 To Sales Agent Agreement (“Amendment”) is made
this 6th day of November 2003, between Altus Medical, Inc. (“Altus”) and PSS World Medical, Inc. (“PSS”). 
  
 WHEREAS, Altus and PSS entered into that February 14, 2003 Sales Agent Agreement and that March 17, 2003 Amendment No. 1 To Sales Agent Agreement
(collectively, “Agreement”), and are hereby amending the Agreement as follows: 
  
 1. Recital C. is hereby deleted and replaced with the following: 
  
 “C. The parties desire that PSS act as a distributor for certain of Altus’ products pursuant to the terms and conditions
herein.” 
  
 2. Sections 1.2, 3.4 and 5.4 are hereby deleted. Also deleted is
the second sentence of Section 4.1, and the second, third and fourth sentences of Section 14.2.(c). 
  
 3. Section 1.4 is hereby deleted and replaced with the following: 
  
 “1.4 Products means Altus’ CoolGlide CV-, CoolGlide Excel-, CoolGlide Vantage-, CoolGlide Genesis-, CoolGlide Xeo- and CoolGlide Genesis Plus systems. Notwithstanding any other term in this Agreement,
Altus may from time to time discontinue the manufacture and/or sale of any or all Products, and/or change its service policies, warranties and product designs without any obligation or liability to PSS. Products will be newly manufactured but may
contain used components. Any software and/or firmware included with the Products are licensed (and not sold) to PSS. Altus grants to PSS a nonexclusive license (transferable only to PSS’ customers) to use such software and/or firmware in
connection with the use of the Products. PSS may not modify, decompile or reverse engineer any such software or firmware. No other license, by implication or otherwise, is granted to PSS.” 
  
 4. Section 2.1 is hereby deleted and replaced with the following: 
  
 “2.1 Appointment. Subject to the terms and conditions of this Agreement, Altus
hereby appoints PSS as its exclusive third party distributor of the Products to licensed physicians (“Physicians”) in the Territory, and PSS accepts such appointment. Altus agrees to sell Products to PSS, and PSS agrees to purchase the
same from Altus only for resale to Physicians for delivery and use within the Territory, under the terms and conditions herein. The ‘exclusivity’ of this appointment means that Altus will not appoint any other third-party distributors to
resell Products to Physicians for delivery and use within the Territory. (For purposes of the foregoing sentence, an entity that is a beauty- or spa chain or franchise or otherwise an entity that may purchase multiple units of Products foritself and
its affiliates will not be deemed to be a ‘distributor.’) Notwithstanding any other term in this Agreement, Altus reserves the right, without any compensation owing to PSS, to market and sell the Products in the Territory through its
employees and third-party leasing companies.” 
  
 5. Section 2.4 is hereby
deleted and replaced with the following: 
  
 “2.4 Orders. 

 

 15 

 a. PSS will submit purchase orders for the Products from time to time, and each order
will be subject to Altus’ acceptance. Each order will specify the types and quantities of requested Products, and the proposed delivery dates and destination points. No other terms or conditions on any PSS order shall be binding on Altus unless
expressly accepted in writing by Altus. The terms and conditions of this Agreement shall be incorporated into each PSS order. In the event of any conflicts, differences or inconsistencies between the terms and conditions of this Agreement and those
of any PSS order, the terms and conditions of this Agreement shall govern. PSS will provide Altus with the contact information of each entity that purchases Products from PSS. 
  
 b. PSS will provide Altus monthly with written forecasts, containing non-binding projections of the types
and quantities of Products PSS expects to purchase during a rolling six-month period from the date of that Forecast, broken down by months. 
  
 c. Title and risk of loss and damage will pass to PSS at Altus’ factory. Products are deemed accepted upon shipment. Delivery dates
are approximate only. Products may be drop shipped to PSS’ customers. PSS may, without any liability to Altus, cancel an order in whole or in part anytime before original scheduled shipment date; provided, that written notice of cancellation
must be received by Altus prior to such date. 
  
 d. Products may be returned only under warranty and only after PSS has obtained a Return Material Authorization (RMA) number from Altus. Returned Products must be shipped to Altus’ factory with freight and insurance prepaid by
Altus.” 
  
 6. Section 3.3 is hereby deleted and replaced with the following:

  
 “3.3.a. If the Prospect is an Altus
Prospect, then PSS will not sell, or attempt to sell, any Products to that Prospect for one hundred twenty days from the date that Altus notified PSS that that is an Altus Prospect. Notwithstanding the foregoing, but subject to the provisions of
Section 2.2, nothing herein shall prohibit PSS from calling, communicating with, marketing to or selling non-Altus Products to Altus Prospects. 
  
 3.3.b. If the Prospect is not an Altus Prospect, than Altus will not sell, or attempt to sell, any Products to that Prospect for one
hundred twenty days from the date that PSS first identified it to Altus as a Prospect.” 
  
 7. The third sentence of Section 5.2 is hereby deleted and replaced with the following: 
  
 “Altus shall provide demonstrations of the Product to Prospects as needed, and will provide all installation work for Products. Altus
agrees to provide sales and promotional support and after-sale service support to all Prospects and PSS customers with the same diligence, quality and timeliness as Altus provides to its Prospects and customers.” 
  
 8. Section 5.3 is hereby deleted and replaced with the following: 
  
 “By December 1, 2003, the parties will negotiate in
good faith and sign a marketing agreement. Under the terms of that agreement: (i) Altus will provide sales literature, marketing material and competitive information (“Marketing Materials”), in such reasonable quantities as may hereafter
be agreed in writing by the parties, for use by PSS in connection with its marketing and distribution efforts hereunder; and, (ii) PSS will allow Altus, at costs to be mutually agreed to by the parties, to participate in PSS’ sales 

 

 16 

 and marketing events, including product fairs, workshops and sales meetings, and to list Altus’ Products in
PSS’ catalogs.” 
  
 8a. Section 5.5 is hereby deleted and replaced with
the following: 
  
 “5.5 Altus shall maintain product liability and
commercial general liability insurance policies with coverage in at least the amount of two million dollars ($2,000,000). Altus shall provide proof of such insurance upon the request of PSS.” 
  
 8b. The following is added as Sections 6.3 and 6.4: 
  
 “6.3 Altus shall comply with all laws, regulations and orders relating to its
performance under this Agreement, including without limitation all anti-fraud and anti-kickback laws, regulations and orders. 
  
 6.4 Altus shall not, directly or indirectly, pay any compensation, amounts, benefits or other consideration to any PSS employee, or any family member of a PSS employee,
(other than customary gifts valued under $100 in the course of one year, and business meals in the ordinary course) without the express written consent of PSS. This section shall survive termination or expiration of this Agreement for any
reason.” 
  
 9. Section 7.1 is hereby deleted and replaced with the
following: 
  
 “7.1 Product Warranty. Products sold pursuant to this
Agreement will come with Altus’ then-current product warranty, which will be solely for benefit of, and assignable to, PSS’ customers. Altus’ current product warranty is attached hereto as Exhibit B; provided, that Altus may from time
to time modify this warranty without any obligation or liability to PSS.” 
  
 10. Section 8 is hereby deleted and replaced with the following: 
  
 “8.0 Price and Payment. 
  
 8.1. Price. The purchase
prices to PSS for the Products will be as set forth in Exhibit A, attached hereto. The difference between the Purchase Price and PSS’ selling price (which shall be determined in PSS’ sole discretion) shall be PSS’ sole compensation
for sales of the Products. Freight and insurance will be prepaid by Altus and is included in the purchase price. Prices exclude taxes, which are PSS’ responsibility (excluding only taxes based on Altus’ net income). Wherever applicable,
all such taxes may be added to the invoice or invoiced separately. 
  
 8.2.
Payment. Payment terms are fifty (50) days from the date of Altus’ invoice. Delinquent invoices shall have a late payment charge of the lesser of eighteen percent per year or the maximum legal rate assessed against any unpaid balance
from the original due date until the date of payment. (Any payments owing by Altus to PSS hereunder will be due fifty (50) days from the date of PSS’ invoice, and will be subject to the foregoing late-payment charge.) Altus may withhold
shipments if PSS is delinquent in making payments or in breach of this Agreement. Until the full purchase price has been received by Altus, Altus shall retain a security interest in the Products (and any proceeds thereof) and the right to immediate
possession thereof (without prejudice to any other available remedies). PSS shall, from time to time, take all acts requested by Altus to transfer, create, perfect, preserve and/or enforce this security interest.” 
  

 17 

 11. Section 14.2.(c) is hereby deleted and replaced with the following: 
  
 “Notwithstanding Section 14.1, either party may
terminate this Agreement, without cause, by delivering a written notice to the other party, which termination will take effect 180 days following delivery of such written notice. After 90 days following delivery of such notice, PSS’ appointment
will convert to ‘nonexclusive,’ meaning that Altus may, without any compensation owing to PSS, appoint third parties to market, sell and distribute the Products to Physicians in the Territory. PSS and Altus agree to work cooperatively in
this transition period.” 
  
 11a. Section 14.5 is hereby
deleted and replaced with the following: 
  
 “14.5 Immediately upon the termination of this Agreement, PSS will discontinue holding itself out as an authorized Altus distributor, and will return to Altus at PSS’ expense, or destroy, all price lists, catalogs, Marketing
Materials and all other sales aids that were furnished by or through Altus to PSS hereunder.” 
  
 12. A new Section 17 is hereby added to the Agreement as follows: 
  
 “17. PSS’ Agreements With Its Customers. All sales and other agreements between PSS and its
customers are PSS’ exclusively, and shall have no effect on the respective obligations of Altus and PSS under this Agreement.” 
  
 13. Exhibit A is hereby deleted and replaced with the following: 
  

“Product Pricing 
  
 For Products sold to PSS from the date of this Amendment until March 31, 2004, the unit pricing will be as set forth below. The pricing
for Products sold after March 31, 2004 will be negotiated by the parties in good faith at least two months before that date. All Product pricing information will be deemed Altus’ Confidential Information. 
  

					
	 Product
	  	 	Unit Price	 
	 CoolGlide CV
	  	$	[****	]
	 CoolGlide Genesis
	  	$	[****	]
	 CoolGlide Excel
	  	$	[****	]
	 CoolGlide Genesis Plus
	  	$	[****	]
	 CoolGlide Vantage
	  	$	[****	]
	 CoolGlide Xeo
	  	$	[****	]
	 	  	 	“	 

  
 14. The parties agree
to discuss in good faith the possible opportunity of PSS distributing Altus’ product upgrades to Physicians in the Territory. 
  
 // 
  
 // 
  
 ****    Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 
  

 18 

 The capitalized terms that are used, but not defined, in this Amendment shall have the same definitions provided in the
Agreement. Except as expressly stated in this Amendment, the Agreement shall remain unmodified and in full force and effect. 
  

									
	 Altus Medical, Inc.
	 	 	 	 PSS World Medical, Inc.

					
	By:	 	/s/    Kevin P. Connors        	 	 	 	By:	 	/s/    Gary A. Corless        
	 	 	
	 	 	 	 	 	

					
	Printed:	 	Kevin P. Connors	 	 	 	Printed:	 	Gary A. Corless
	 	 	
	 	 	 	 	 	

					
	Its:	 	CEO	 	 	 	Its:	 	President
	 	 	
	 	 	 	 	 	

  

 19 

 Exhibit B 
  
 Altus’ Product Warranty (as of the date of this Amendment) 
  
 Altus warrants solely to the end-user customer for one year from initial shipment of a Product that such Product will be free from defects in workmanship and materials.
This warranty is subject to proper use, operation and maintenance of the Product in accordance with the operator manual, and shall not apply if the Product has been damaged after delivery, or misused, altered, disassembled or serviced by any person
other than Altus. Altus’ sole obligation under this warranty shall be, at Altus’ option, to repair or replace any Product defect that was present when the Product was first shipped, or to refund the applicable purchase price upon the
return of the Product to Altus. Repaired or replacement Products or components thereof will be warranted as provided in this subsection for either the remainder of the original Product’s original warranty period or thirty days from when the
defective Product or component was repaired or the replacement Product or component was first shipped, whichever is longer. Product upgrades and components purchased separately (including the Cool Glide Xeo hand piece) will be warranted as provided
in this section for either the remainder of the related Product’s original warranty period or ninety days from initial shipment, whichever is longer. Software and firmware licensed herein will be warranted as provided in this subsection for
ninety days from initial shipment. Altus makes no warranties with respect to a Product’s removable hand piece window. THE FOREGOING PRODUCT WARRANTIES AND REMEDIES ARE EXCLUSIVE AND IN LIEU OF ALL OTHERS. EXCEPT AS SO STATED, ALTUS DISCLAIMS
ALL PRODUCT WARRANTIES, EXPRESS AND IMPLIED, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. 
  

 20Deed of Trust

 EXHIBIT 10.65 
  
 DEED OF TRUST 
  
 DATED AS OF DECEMBER 29, 2003 
  
 MADE BY 
  
 OMEGA PROTEIN, INC. 
  
 TO 
  
 MATSON C. TERRY,
II, OF 
  
 NORTHUMBERLAND COUNTY, VIRGINIA 

 
 AND 
  
 B.H.B. HUBBARD, III, OF 
  
 LANCASTER COUNTY, VIRGINIA, TRUSTEES 
  
 FOR THE BENEFIT OF 
  
 THE UNITED STATE OF AMERICA 
  

 1 

 DEED OF TRUST AND SECURITY AGREEMENT 
  
 COMMONWEALTH OF VIRGINIA 
  
 COUNTY OF NORTHUMBERLAND 
  
 1. PARTIES: WHEREAS, OMEGA PROTEIN, INC., a Virginia corporation, hereinafter “Grantor”, whether one or more, is
indebted to the UNITED STATES OF AMERICA acting by and through the Secretary of Commerce, Office of the Financial Services Division, National Marine Fisheries Service, National Oceanic and Atmospheric Administration, hereinafter
“Beneficiary”, in the aggregate amount of Five Million, Three Hundred Thousand, and No/100 Dollars ($5,300,000.00), together with interest thereon, as evidenced by a certain promissory note, payable to the order of the United States of
America, acting by and through the Secretary of Commerce, Office of the Financial Services Division, National Marine Fisheries Service, National Oceanic and Atmospheric Administration, which bears interest and is payable according to the terms of
said note and which has a final maturity date of December 29, 2018. 
  
 2. THE PROMISSORY NOTE TO THE UNITED STATES OF AMERICA: NOW, THEREFORE, in consideration of the premises and in order to secure the prompt and full payment of said indebtedness, and any future advance(s), additional advance(s), and/or
readvance(s), and/or any renewal(s), extension(s), restructuring(s), reamortization(s), any other sums provided for in any loan document, and/or any other loan treatment(s) thereof, or any part thereof, and the interest thereon and any and all other
indebtedness(es) (including future advance(s) now or hereafter owed by any of the undersigned to the Beneficiary), whether such indebtedness(es) is primary or secondary, direct or indirect, contingent or absolute, matured or unmatured, joint or
several, and otherwise secured or not, and the faithful performance of and compliance with all the terms, agreements, provisions, obligations, covenants, conditions, warrants, representations, and stipulations herein made, or made in any Loan
Agreement or in any other document related to the promissory note described as follows: 
  
 (a.) The Promissory Note to the United States of America executed by Grantor in the principal amount of Five Million, Three Hundred thousand & No/100 Dollars, ($5,300,000.00), with interest on the unpaid principal
computed from the 29th day of 

  

 2 

 
December, 2003, at the rate of Six and six tenths per cent (6.6 %) per year, payment to be made in installments of One hundred thirty-nine thousand eight
hundred twenty-nine and No/100 Dollars ($139,829.00), including principal and interest quarterly, with the balance of principal and interest due 15 years from the date of said Note. The first quarterly payment shall be due on the 29th day of March,
2004, and each quarterly payment thereafter shall be due on the day of the month that the first quarterly payment is due thereunder. 
  
 3. THE PROPERTY: OMEGA PROTEIN, INC., hereinafter Grantor, whether one or more, in consideration of the premises and other good and valuable consideration
paid to Grantor by Matson C. Terry, II, Esq., and B.H.B. Hubbard, III, Esq., as Trustees, either of whom may act, whose address is 293, Steamboat Road, P.O. Box 340, Irvington, Virginia 22480, hereinafter, “Trustee”, does hereby convey and
warrant unto Trustees with General Warranty the real estate, hereinafter “The Property”, situate in Northumberland County, Virginia, more particularly described on Exhibit A, attached hereto, recorded herewith, and, by this reference,
expressly made a part hereof for a further and more accurate description of the real estate hereby encumbered, together with all buildings and other improvements, hereditaments and appurtenances thereunto belonging, or in any wise appertaining now
existing or hereafter erected upon the premises and all the income and rents arising therefrom. Grantor does hereby intend to convey and does convey all of Grantor’s right, title and interest in and to any strips and gores Grantor may now own
contiguous to the above described property. 
  
 4. MINERALS
INCLUDED: It is expressly understood and agreed, as a part of the consideration for the loan made to the Grantor and secured by the premises hereinabove described, that this instrument covers and includes all surface, subsurface and/or mineral
estate ownership now or after acquired by the undersigned in the above-property and whether or not expressly excepted from the description to the above security premises, any provisions herein to the contrary being of no force and effect.

  
 5. PLEDGE OF PERSONAL PROPERTY: AND FOR THE CONSIDERATION
AFORESAID, and as further security for any and all debt(s) and obligation(s) described above, said Grantor does hereby assign, pledge and transfer to the Beneficiary, and grant to the Beneficiary a security interest in and to the following described
property and interests, to-wit: (1) all timber of all 

  

 3 

 
kind, character and description planted and/or growing, or to be planted and/or grown, on the hereinabove described property; (2) all crop allotments,
quotas, and/or (3) all rents, profits, issues, income, royalties, bonuses, and revenues of said property, or any part or interest herein, from time to time accruing whether under leases or tenancies now existing or hereafter created; (4) each and
every policy of hazard insurance or the like now or hereafter in effect which insures said property or any building, fixture and/or improvement thereon or any part thereof, together with all the right, title and interest of Grantor in and to such
policy, including but not limited to any premiums paid (or rights to return premiums) and/or all proceeds or payments thereunder; (5) all judgments, award of damages and settlements hereafter made resulting from condemnation proceedings or the
taking of the real property, or any part thereof, under the power of eminent domain, or for any damage (whether caused by such taking or otherwise) to the property, or any part thereof, or to any rights appurtenant thereto; (6) all building
materials, equipment, fixtures and fittings of all kind, character, and description used in connection with or relating to said property and/or buildings, fixtures or improvements thereon; (7) all equipment, including, but not limited to: forklifts,
bobcats, cranes, pallet trucks, lift trucks and other product or material movement equipment of whatsoever nature; all trailers, tanks, trucks, or other rolling stock of whatsoever nature; all fish unloading, transfer and conveying equipment of
whatsoever nature; all fish processing equipment of whatsoever nature; all fish weighing equipment of whatsoever nature; all cooling, refrigerating, freezing and other fish holding equipment (blast freezers, plate freezers, coolers, or other
refrigeration equipment) of whatsoever nature; all fish packaging equipment of whatsoever nature; all fish baskets, totes, tanks, tubs, and other fish holding equipment of whatsoever nature; all ice makers of whatsoever nature; all hand and power
tolls of whatsoever nature; all office equipment of whatsoever nature; all fish hatching, releasing, rearing, growing, tending, and other equipment of whatsoever nature in any way associated with fisheries cultivation of every sort-all together with
all associated equipment, machinery, parts, tools, or other items of whatsoever nature and whether fixed or unfixed to the Project Property or any other premises whatsoever; and/or (8) all tangible or intangible property found on the premises and
products, proceeds, and additions and/or replacement of any or all of the property described above in items 1 through 8. 
  

 4 

 Additionally, Grantor does hereby assign, pledge and transfer to the Beneficiary, and grant to the
Beneficiary a security interest in any transferable fishing conservation and management allocation (including, but not limited to, allocations, permits, quotas, licenses, cage tags, or any other fisheries access restriction or right, however
characterized, of whatsoever nature) affecting, necessary for, or in any other way, however characterized, associated with any of the property included in the collateral, the Grantor agrees to grant to the Beneficiary a full senior security interest
in such allocation by whatsoever means deemed by the Beneficiary to be appropriate (including, but not limited to, the Grantor’s execution of security agreements and the filing of financing statements under the UCC), presently owned or acquired
at any time in the future. Further, if the Grantor fails to do so, the Grantor agrees that the Beneficiary may use, for the purpose of executing and otherwise perfecting whatever documents may be required to effect the grant to the Beneficiary of
such a full security interest in such fisheries conservation and management allocation, the attorney-in-fact authority conferred upon the Beneficiary by Article XI of the Title XI Financial Agreement. 
  
 IN TRUST, however, to secure and enforce the repayment of all of
Grantor’s obligations under the promissory note set forth above and to secure Grantor’s promises contained hereinafter. 
  
 GRANTOR FURTHER COVENANTS, WARRANTS AND AGREES: 
  
 7. TAXES, FEES: To pay when due all taxes, liens, judgments, assessments or fees assessed against said property and to promptly furnish Beneficiary with
tax receipts or like documents evidencing payment of or release from all taxes, liens, judgments, assessments or fees. By execution hereof, Grantor agrees to pay when due all community water system assessment and meter fees, if any, applicable to
said property, and in the event of foreclosure, hereby does transfer and assign to the purchaser all of Grantor’s interest and membership, if any, in said community water system applicable to said property, and agrees to execute such documents
as are necessary to effectuate such transfer. 
  
 8. INSURANCE
REQUIREMENT: To insure and keep insured buildings and other improvements now on or which may hereafter be placed on said premises, against loss or damage by fire, water windstorm and/or all hazards included within “extended coverage”, as
well as loss or damage by flood in areas designated by the U.S. Department of Housing and Urban Development as 

  

 5 

 
subject to flood, any policy evidencing such insurance to be deposited with, and the loss thereunder to be payable to Beneficiary as its interest may appear,
and providing for immediate notification to Beneficiary of any lapse, cancellation or other impairment of said insurance. All policies shall be written by reliable insurance companies authorized to write policies of insurance in the State of
Virginia, acceptable to Beneficiary. At the option of Beneficiary, and subject to the general regulations of U.S. Department of Commerce, where applicable, sums received by Beneficiary from such insurance companies may be used to pay for
reconstruction or repair of destroyed or damaged buildings or improvement(s); or, if not so applied may, at the sole option of the Beneficiary, be applied in payment of any indebtedness, matured or unmatured, secured by this deed of trust and
security agreement. The Beneficiary will be listed on any insurance policy and named as First Loss Payee on all insurance covering real property, except Liability coverage, in which case the Beneficiary is named a Loss Payee as its interest may
appear. The Beneficiary will also be listed as a First Loss Payee on all insurance covering personal property, as its interest may appear. 
  
 9. USE OF THE PROPERTY: That the aquaculture portion of the premises hereinbefore described, if any, shall be continuously used in a husbandlike manner
for aquaculture production which incorporates good aquaculture practices that will produce the maximum yield consistent with conservation goals; that in the event that any part of the premises is used for agriculture, it shall be conducted in a
husbandlike manner, that Waste will not be committed or permitted; if timber land is involved as security, Grantor will follow good and approved forestry practices to minimize or prevent fire danger, erosion or depreciation, protect young trees, and
maintain forest production; it is agreed, however, that no timber now or hereafter affected hereby will be cut, removed, damaged or turpentined (except such as is customarily used on the property for fuel, fencing or repairs) without the prior
written consent of the Beneficiary. Grantor will promptly notify Beneficiary of any damage to timber from any source. Grantor will, where practical, promptly notify Beneficiary of any potential damage to timber. In the event this covenant, or any
part, is breached, Grantor agrees to pay all costs and expenses, including reasonable attorney’s fees, incurred by Beneficiary in investigating such violation and in protecting and preserving this security. 
  
 10. EVENTS OF DEFAULT-REMEDIES: This conveyance, however, is in trust to
secure the payment and performance of the obligations. But if Grantor fails to pay when due any 

  

 6 

 
sums secured hereby or if default is made by Grantor (or any one of them) in the payment or performance of any of the obligations under the Note, Promissory
Note to the United States, Deed of Trust and Security Agreement, Title XI Agreement, or any other document or agreement associated with this transaction, or in case Grantor should become insolvent, commit an Act of Bankruptcy, or apply to a
bankruptcy court to be adjudicated a voluntary bankrupt, or proceedings be instituted to put Grantor in involuntary bankruptcy, or should any proceedings be taken against Grantor for the appointment of a receiver, assignee or trustee, or should
Grantor make an assignment for benefit of one or more creditors, or should Beneficiary in good faith deem itself insecure and its prospect of payment impaired, or if any loan proceeds are used for a purpose that will: (1) contribute to excessive
erosion of highly erodible land or to the conversion of wetlands to produce an agricultural commodity, as further explained in 7 CFR Part 1940, Subpart G, Exhibit M, or (2) result in poor aquaculture practices, then in that event all of the
obligations shall, at the option of Beneficiary, be and become at once due and payable without notice to Grantor, and Trustee herein named or his successor or successors shall, at the request of Beneficiary, sell all or any part of the Property as
set out in ¶ 30 of this Deed of Trust and Security Agreement. In the event of any such default, Beneficiary shall also have all the remedies of a secured party under the Uniform Commercial Code of Virginia and any other applicable law,
including, but not limited to the right to seek a judgment for any deficiency in the amount owed, following liquidation of collateral. All remedies of Beneficiary shall be cumulative. A failure on the part of Beneficiary to exercise any remedy or
option contained in this Deed of Trust and Security Agreement in the event of default shall not constitute a waiver of Beneficiary’s right to exercise said remedy or option in the event of that or any subsequent default. 
  
 11. COMPLIANCE WITH ALL REGULATIONS: With respect to the Property, Grantor
covenants with Beneficiary, that Grantor has complied, is in compliance, and will at all times comply in all respects with all applicable laws (whether statutory, common law or otherwise), rules, regulations, orders, permits, licenses, ordinances,
judgments, or decrees of all governmental authorities (whether federal, state, local or otherwise), including, without limitation, all laws regarding public health or welfare, environmental protection, water and air pollution, composition of
product, underground storage tanks, toxic substances, hazardous substances, hazardous materials, hazardous wastes, other wastes or used oil, asbestos, occupational health and safety, nuisances, trespass, and negligence. 
  

 7 

 12. HOLD HARMLESS AGREEMENT: Grantor agrees to indemnify and hold Beneficiary, its directors, employees,
agents, and its successors and assigns, harmless from and against any and all claims, losses, damages, liabilities, fees, penalties, charges, judgments, administrative orders, remedial action requirements, enforcement actions of any kind, and all
costs and expenses incurred in connection therewith (including but not limited to, attorney’s fees and expenses, including all attorney’s fees and expenses incurred by Beneficiary in and for this indemnity), arising directly or indirectly,
in whole or in part out of any failure of Grantor to comply with the environmental representations, warranties and covenants contained herein. 
  
 13. SURVIVAL OF GRANTOR’S LIABILITY: Grantor’s representations, warranties, covenants and indemnities contained herein shall survive the
occurrence of any event whatsoever, including without limitation, the satisfaction of the promissory note secured hereby, the reconveyance or foreclosure of the mortgage, the acceptance by Beneficiary of a deed in lieu of foreclosure, or any
transfer or abandonment of the property, failure to comply strictly with the representations, warranties, covenants and indemnities commenced herein shall constitute a default under this deed of trust. 
  
 14. VALID SIXTH LIEN: That this deed of trust and security agreement is a
valid sixth lien against all the land, interests and improvements offered and/or appraised as security for this loan and that the property and interests described herein is now free and clear of any and all other liens and encumbrances except as
otherwise set forth herein. If the validity of this deed of trust, or if Grantor’s title to any of said land, interests or improvements is questioned in any manner, or if any part of such land, interests or improvements is not properly
described herein, Beneficiary may, in its discretion, investigate and take such action as it considers necessary or desirable for the protection of its interests and for this purpose may employ legal counsel or expert assistance and the Grantor will
promptly pay all expenses so incurred by Beneficiary. 
  
 The lien
of this deed of trust is subordinate and of inferior dignity to the lien of that certain prior deed of trust dated July 18, 1989, from Zapata Haynie Corporation to Michael T. Bradshaw, et al, Trustees, securing the United States of
America in the original amount of $4,675,000.00, recorded 

  

 8 

 
in Deed Book 298, at Page 80, in the Clerk’s Office of the Circuit Court of Northumberland County, Virginia, as amended by that certain Amendment dated
March 31, 1993, recorded in Deed Book 348, at Page 130, in the Clerk’s Office aforesaid. 
  
 The lien of this deed of trust further is subordinate and of inferior dignity to the lien of that certain prior deed of trust dated October 30, 1996, from Zapata Protein (USA), Inc., to James C. Breeden, et
al, Trustees, securing the United States of America in the original amount of $1,848,562.00, recorded in Deed Book 407, at Page 706, in the Clerk’s Office of the Circuit Court of Northumberland County, Virginia. 
  
 The lien of this deed of trust further is subordinate and of inferior dignity
to the lien of that certain prior deed of trust dated May 12, 1998, from Omega Protein, Inc., to Matson C. Terry, II, et al, Trustees, securing the United States of America in the original amount of $2,593,761.00, recorded in Deed Book
431, at Page 200, in the Clerk’s Office of the Circuit Court of Northumberland County, Virginia. 
  
 The lien of this deed of trust further is subordinate and of inferior dignity to the lien of that certain prior deed of trust dated December 21, 1999,
from Omega Protein, Inc., to Matson C. Terry, II, et al, Trustees, securing the United States of America in the original amount of $2,030,661.00, recorded in Deed Book 460, at Page 721, in the Clerk’s Office of the Circuit Court
of Northumberland County, Virginia. 
  
 The lien of this deed of
trust further is subordinate and of inferior dignity to the lien of that certain prior deed of trust dated October 19, 2001, from Omega Protein, Inc., to Matson C. Terry, II, et al, Trustees, securing the United States of America in
the original amount of $1,900,000.00, recorded in Deed Book 495, at Page 338, in the Clerk’s Office of the Circuit Court of Northumberland County, Virginia. 
  
 15. GRANTOR TO PAY EXPENSES: That if Grantor defaults in any of the provisions of this Deed of Trust and Security Agreement,
particularly, but not limited to, ¶¶ 7, 8, 9 or 14, then Beneficiary may pay such taxes, liens, judgments or assessments, obtain and pay for such insurance, advance such attorney’s fees, expenses and costs, or take any other action or
incur any other expenditures that Beneficiary determines are necessary to protect Beneficiary’s interests and Grantor agrees to immediately pay Beneficiary all amounts so advanced and that all amounts so advanced shall be secured hereby.

  

 9 

 16. USE OF PROCEEDS: That all representations and statements made in the application for this loan are
true and correct, that the proceeds of this loan will be used solely for the purposes specified in said application and that Grantor will comply with all requirements and conditions imposed by Beneficiary in making this loan. 
  
 17. NON-ALIENATION CLAUSE: To not sell, assign or convey any part or all of
the mortgaged premises (regardless of whether the buyer or assignee “assumes” the note or takes the mortgage premises “subject to” such note, or whether by contract for deed or sale) without first obtaining the Beneficiary’s
prior written consent as long as the above note, or any part, or any other sum owed to the Beneficiary, remain unpaid. If Grantor is a corporation, not to change the substantial ownership and/or control of said corporation without first obtaining
the Beneficiary’s prior written consent as long as the above note, or any part, or any other sums owed to the Beneficiary, remain unpaid. 
  
 18. PROMPT PAYMENT PROVISION: That all payments of principal and interest (or any part thereof) not made when due shall bear interest from due date to the
date of payment thereof by maker or assumptor at the default rate which is equal to eighteen percent (18%) per annum. All advances made by the holder hereof shall be secured by and under this Deed of Trust and Security Agreement and shall be payable
with interest from the date each advance is made until paid by maker or assumptor at the default rate. 
  
 19. RELEASE PROVISION: That Beneficiary may at any time, without notice, release any of the property described herein, grant extensions or deferments of
time of payment of the indebtedness secured hereby, or any part thereof, grant subordinations of lien(s) or release from liability any parties who are or may become liable for the payment of said indebtedness, without affecting the priority of this
lien or the personal liability of the Grantor or any other party liable or who may become liable for the indebtedness secured by this instrument. If all or any part of the property hereinabove described becomes vested in any party other than
Grantor, Beneficiary may, without notice to Grantor, deal with such successor in interest with reference to this instrument and the debt(s) and obligation(s) hereby secured in the same manner as with the Grantor, without in any 

  

 10 

 
way releasing, vitiating or discharging the Grantor’s liability hereunder or for the debt(s) and obligation(s) hereby secured and extension(s) of time
for payment or other loan treatment(s) described herein given or permitted by Beneficiary shall not operate to release, vitiate, or discharge the liability of the Grantor herein, either in whole or in part. 
  
 20. BENEFICIARY NON-WAIVER: That the failure of Beneficiary to exercise any
option or make any decision or election under any term or covenant herein expressed shall not be deemed a waiver of the right to exercise such option or to make such decision or election at any time. 
  
 21. SUCCESSORS & ASSIGNS BOUND: That each covenant and agreement herein
contained shall inure to the benefit of and bind the successors and assigns of Beneficiary and Grantor. 
  
 22. SUBSTITUTE TRUSTEE: Beneficiary may, without notice to any party to this Deed of Trust and Security Agreement, or to the successors or assigns, and
without regard to the willingness or inability of Trustee to act, or to execute this trust, appoint another person or succession of persons to act as Trustee herein, and such appointee or substitute shall have all the title, authority and powers in
the execution of this trust as are vested in Trustee. If Beneficiary be a corporation such appointment may be made by any one of its officers or agents. No single exercise of this power of appointment, the power of sale, or any other power or right
given in this Deed of Trust and Security Agreement shall exhaust the right to exercise such power but all rights and powers herein given may be exercised as often as may be necessary for the collection of all amounts secured by this Deed of Trust
and Security Agreement until said amounts are fully paid and discharged. At any sale hereunder, Trustee may from time to time, adjourn said sale to a later date without re-advertising the sale by giving notice of the time and place of such continued
sale at the time Trustee shall make such adjournment. And at any sale made to enforce the trust herein given, Beneficiary or any person in interest may become a purchaser and upon payment of the purchase price, Trustee shall provide a deed of
conveyance by Special Warranty, which conveyance shall vest full and perfect title in such purchaser upon payment of the purchase price. 
  
 23. LIFE INSURANCE: That in the event Grantor purchases life insurance (group, credit or other) in connection with this loan but subsequently fails to pay
the premium to keep same in force, the Beneficiary, at its option, may pay such premium on Grantor’s behalf, charge such 

  

 11 

 
payment to the loan, and such advance of premiums shall be secured by this mortgage and bear interest the same as other advances provided for in this Deed of
Trust and Security Agreement. Any policy evidencing such insurance to be deposited with and any loss thereunder to be payable to Beneficiary as its interest may appear. 
  
 24. FINANCIAL STATEMENT: To furnish to the Beneficiary annually a financial statement and income statement attested to by
Grantor or verified by a public accountant. 
  
 25. DEATH OF
SIGNATORY: All parties to this deed of trust or to the note hereby secured covenant and agree that upon the death of any signatory, maker, or comaker of such note the owner and holder of said note may, at holder’s option, mature or accelerate
the entire balance owing on said note whereupon all amounts owing by virtue thereof shall be immediately due and payable. 
  
 26. INSPECTION: The Grantor hereby grants and will cause any tenants to grant to Beneficiary, its agents, attorneys, employees, consultants, contractors,
successors and assigns, an irrevocable license and authorization upon reasonable notice to enter upon and inspect the Property and facilities thereon and perform such tests, including without limitation, subsurface testing soils and groundwater
testing and other tests which may physically invade the Property thereon, as the Beneficiary, in its sole discretion, determines is necessary to protect its security interest, provided however, that under no circumstances shall the Beneficiary be
obligated to perform such inspections or tests. Any such inspections or tests shall be at the sole cost of the Grantor. 
  
 27. NONTRANSFERABILITY: Except as provided by regulations of the Beneficiary neither the property or any portion thereof or interest therein shall be
leased, assigned, sold, transferred, or encumbered, voluntarily or otherwise, without the prior written consent of the Beneficiary. The Beneficiary shall have the sole and exclusive rights as Beneficiary hereunder, including but not limited to the
power to grant consents, partial releases, subordinations and satisfaction, and no insured holder shall have any right, title and interest in or to the lien or any benefits hereof. 
  
 28. ACCELERATION OPTION: If all or any part of the Property or an interest therein is sold, transferred, encumbered or
otherwise disposed of by Grantor without Beneficiary’s prior written consent, Beneficiary may, at Beneficiary’s option, declare all of the obligations to be immediately due and payable. Beneficiary shall have waived such option to
accelerate if, prior to the 

  

 12 

 
sale or transfer, Beneficiary and the person to whom the Property is to be sold or transferred reach agreement in writing that the credit of such person is
satisfactory to Beneficiary and that the interest payable on the sums secured by the Deed of Trust and Security Agreement shall be at such rate as Beneficiary shall request and the party assuming the obligations meets the criteria set out in Title
XI for all borrowers. Regardless of any assumption or transfer of the Property and/or the obligations arising under the Deed of Trust and Security Agreement, Grantor will not be released from any obligation to Beneficiary until the entire debt and
all sums associated therewith are paid in full. If Beneficiary exercises such option to accelerate, Beneficiary shall mail Grantor notice of acceleration. Such notice shall provide a period of not less than 30 days from the date of notice is mailed
within which Grantor may pay the sums ordered due. If Grantor fails to pay such sums prior to the expiration of such period, Beneficiary may, without further notice or demand on Grantor, invoke any remedies permitted by this Deed of Trust and
Security Agreement, or any other security document associated with this transaction. 
  
 29. PAYMENT OF ADVANCES: Now, if Grantor shall pay said indebtedness and any future advances, additional advances, readvances or any other indebtedness in addition to the original indebtedness set forth herein, and
secured hereby, and keep and perform all of the covenants and agreements of this deed of trust, it shall become null and void. 
  
 30. FORECLOSURE AND SALE OF THE PROPERTY: This deed of trust shall be construed to impose and confer upon the parties hereto, and the Beneficiaries
hereunder, all duties, rights and obligations as set forth in Section 55-59, and 55-59.1 through 55-59.4 and 55-60 of the Code of Virginia as now in force and (to the extent that any amendment thereof shall not limit the rights of the Trustees or
Beneficiaries hereunder or the obligations of the Grantor) as hereafter amended; and further to incorporate herein the following provisions by the short form references below, of Sections 55-59 and 55-59.1 through 55-59.4 and 55-60 of the Code of
Virginia: 
  
 ADVERTISEMENT REQUIRED: Four times
in a newspaper 
 published or having general circulation in Northumberland County 
 BIDDER’S DEPOSIT: of Ten Percent (10%) may be required. 
 EXEMPTIONS WAIVED. 
 SUBJECT TO CALL UPON DEFAULT. 
 RENEWAL OR EXTENSIONS PERMITTED. 
  
 Grantor acknowledges that Beneficiary will have the right to seek a
deficiency judgment in the event of default, sale of the property and Beneficiary not being made whole from the proceeds of such sale. 
  

 13 

 31. MULTIPLE COUNTIES: In case the real estate herein described is situated in more than one county or in
more than one judicial district of a county or counties, a foreclosure sale of all of said real estate may be made in any one of the counties or judicial districts in which any part thereof is situated, after giving notice of the time, place and
terms of sale in the manner above described in each county and judicial district in which any part of said land lies. 
  
 32. SURRENDER OF POSSESSION: It is further stipulated and agreed that in case of any sale hereunder Grantor shall immediately surrender possession to the
purchaser. If Grantor fails to do so, Grantor shall become a tenant at sufferance of the purchaser, subject to an action for unlawful entry and detainer. 
  
 33. BENEFICIARY’S RIGHT TO BID: It is expressly agreed between the parties hereto, that in the event of foreclosure and sale, that the Beneficiary
hereunder, or its successors and assigns, may bid at any such sale or sales and may purchase the property secured hereunder if the high bidder therefor, as if Beneficiary were a stranger to this conveyance. 
  
 34. MAILING ADDRESS: For purposes of giving any notice that may be required
by the terms of this deed of trust, Grantor hereby stipulates and agrees that his mailing address is P.O. Box 2866, Hammond, La 70404 and Beneficiary may rely upon this stipulation until such time as Beneficiary has been advised in writing by
Grantor of a change of address. 
  
 35. SEVERABILITY: The
unenforeceability or invalidity of any provision(s) of this Deed of Trust and Security Agreement shall not render any other provision(s) herein unenforceable or invalid. This Deed of Trust and Security Agreement may be amended only by an instrument
in writing, signed by Grantor and Beneficiary, and may not be amended orally or by any course of conduct or otherwise than by written instrument. 
  
 All riders, appendages, exhibits, erasures, corrections and interlineations, if any, have been made and approved before signing hereof. 
  

 14 

 IN WITNESS WHEREOF, the Grantor has caused its name to be signed hereto and its corporate seal affixed
and attested pursuant to corporate resolutions, which resolutions have not been rescinded, revoked or modified. 
  

	
	 Omega Protein, Inc.

	
	 By:

	       Its Controller/Assistant Treasurer

  

	
	 ATTEST:

	
	  

	 STATE OF
                                    ,

	 CITY/COUNTY OF
                        ,

  
 Personally appeared
before me, the undersigned authority in and for said County and State the within named Clark A. Haner, the Controller/Assistant Treasurer, and Robert Stockton, the Secretary, Vice President and Chief Financial Officer of Omega Protein, Inc., who
acknowledged that they signed and delivered the above and foregoing instrument on the day and year and for the purposes therein mentioned as their own voluntary acts and deeds. 
  
 WITNESS my hand and official seal this      day of December, 2003. 
  

	
	
	 
	

	 Notary Public

  
 My commission
expires:                                      
  
 NOTARY AFFIX SEAL HERE! 
  

 15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}]]